Stock search

Ticker or company name

Zimmer Biomet

ZBH · NYSE · Health Care

$101,41Down −1,80 (−1,74%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$18,0 bn
Div. yield
1,0%
Year to date
+14,8%
52 weeks: $79,12$112,55

Ratio score

67/100
Ratio would watch

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

4 ✓ · 4 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM26,025,125,1
Forward P/E10,5—16,2
PEG4,3—2,2
P/S2,33,02,2
EV/EBITDA14,816,017,3
P/FCF17,2—19,5
P/B1,61,83,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 31 analysts

Buy
10
Hold
21
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,901,90Down 0,0%
Q2 20262,032,07Up +2,0%
Q1 20261,882,09Up +11,0%
Q4 20252,422,42Up 0,0%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue2,06 bn2,18 bn2,09 bn2,24 bn2,00 bn2,08 bn1,91 bn2,02 bn1,82 bn1,94 bn1,89 bn1,94 bn
EPS1,001,031,220,711,160,770,911,191,231,180,842,00
Margin9,3%9,1%11,4%6,2%11,5%7,4%9,5%11,8%13,7%12,5%9,1%21,6%
FCF484 m394 m323 m443 m364 m328 m338 m455 m351 m317 m173 m526 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $1,58 m.

NameAmountSharesPrice
thornal kevin r11 Sep 2026 · sale$528 9785 691$92,95
phipps chad f4 Sep 2026 · sale$295 0503 000$98,35
yi sang29 May 2026 · sale$66 128800$82,66
yi sang29 May 2026 · sale$347 0884 200$82,64
winkler lori12 Mar 2026 · sale$250 8492 650$94,66
yi sang12 Feb 2026 · sale$96 4901 000$96,49

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
25 Jul 2001

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
SOLVSolventum$88,65no score96,3——
BAXBaxter International$25,5438would not consider—+5,3%−6,2%
STESteris$261,9175would consider31,9+8,1%13,4%
COOCooper Companies (The)$61,8889would consider20,9+4,7%13,5%
ALGNAlign Technology$165,9889would consider24,1+4,4%11,8%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.